First patient dosed in Fabry Disease gene therapy trial

13th September 2019 Uncategorised 0

The study is the first clinical-stage adeno-associated virus (AAV) gene therapy study globally for Fabry Disease.

More: First patient dosed in Fabry Disease gene therapy trial
Source: News